≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Male genital organ, other/unspecified

Endpoint Browser

CD2_BENIGN_MALE_GEN_NOS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

only males

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D29.7&, D29.9&
  • Hospital discharge: ICD-9 — 222[8-9]
  • Hospital discharge: ICD-8 — 2229
  • Cause of death: ICD-10 — D29.7&, D29.9&
  • Cause of death: ICD-9 — 222[8-9]
  • Cause of death: ICD-8 — 2229

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 37 - 37
Unadjusted period prevalence (%) 0.02 - 0.02
Median age at first event (years) 52.66 - 52.66

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
16
59
4.02
3.95
2.7
1.5
—
—
—
0
0
6
18
3.77
1.83
1.0
1.1
—
—
—
0
0
12
67
2.17
1.22
4.4
2.9
—
—
—
0
0
21
264
0.53
1.01
10.6
12.8
43.0
42.2
%
0.22
14
196
7
43
1.77
0.71
2.3
1.7
—
—
—
0
0
0
21
0.00
0.62
0.0
1.2
—
—
—
0
0
0
22
0.00
0.61
0.0
1.5
—
—
—
0
0
6
92
0.59
0.50
3.5
3.1
9.0
8.6
mmol/l
—
6
82
10
128
0.70
0.34
8.3
5.4
3.4
3.3
%
—
10
118
10
76
1.43
0.32
3.1
4.3
—
—
—
0
0
10
126
0.72
0.30
8.4
5.2
0.6
0.6
%
—
10
116
7
93
0.70
0.26
11.6
5.1
—
—
—
0
0
0
11
0.00
0.22
0.0
2.7
—
—
—
0
0
0
11
0.00
0.22
0.0
1.0
—
—
—
0
0
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
11
131
0.77
0.21
7.9
5.6
26.4
26.1
%
0.03
11
122
12
100
1.30
0.21
2.3
2.3
372.2
5444.7
umol/l
0.50
12
81
7
60
1.20
0.19
2.6
2.1
0.7
2.8
e6/l
—
7
52
7
61
1.18
0.19
6.1
4.6
—
—
—
0
0
32
303
1.41
0.19
19.1
14.6
82.9
88.2
umol/l
1.05
32
303
11
129
0.79
0.18
7.1
5.3
58.0
57.2
%
0.08
11
120
6
74
0.77
0.17
2.5
1.9
2.3
2.3
mmol/l
—
6
65
11
128
0.80
0.17
7.7
5.8
11.0
8.9
%
0.99
11
118
30
285
1.28
0.17
16.3
12.0
21.0
25.0
mg/l
0.38
23
232
23
247
0.82
0.15
3.1
3.9
1.8
2.0
mu/l
0.46
23
225
9
107
0.79
0.15
14.2
6.3
1.2
1.2
mmol/l
—
9
97
12
137
0.82
0.15
16.2
3.3
12.3
14.6
umol/l
0.43
12
130
22
203
1.21
0.14
3.6
3.7
—
—
—
0
0
10
115
0.82
0.13
9.6
3.7
34.9
35.3
g/l
—
10
109
5
44
1.16
0.10
1.6
1.2
—
—
—
0
0
5
46
1.10
0.10
3.6
5.2
1.0
1.0
mmol/l
—
5
41
6
54
1.13
0.09
5.8
2.8
514.2
633.5
mosm/kgh2o
—
6
46
6
55
1.11
0.09
1.2
3.1
510.8
238.2
ng/l
—
6
45
5
63
0.76
0.09
8.6
3.2
—
—
—
0
0
7
62
1.16
0.09
1.4
1.1
—
—
—
0
0
12
108
1.16
0.08
11.5
10.5
1.6
1.3
inr
—
5
27
31
300
1.21
0.08
19.5
12.0
—
—
—
0
0
8
76
1.07
0.08
2.4
2.4
—
—
—
0
0
7
81
0.83
0.08
3.3
2.6
0.0
0.4
e6/l
—
7
65
7
79
0.86
0.08
5.7
2.1
—
—
—
0
0
17
180
0.90
0.05
5.6
3.7
—
—
—
0
0
11
101
1.13
0.04
5.7
3.3
—
—
—
0
0
12
125
0.94
0.00
2.1
3.3
—
—
—
0
0
32
317
1.07
0.00
23.7
17.6
30.9
30.8
pg
0.13
32
310
32
318
1.05
0.00
24.1
17.8
139.1
142.5
g/l
0.50
32
311
9
93
0.96
0.00
4.6
2.5
7.5
11.8
e6/l
—
9
78
30
292
1.14
0.00
18.1
15.2
139.6
139.5
mmol/l
0.09
30
285
0
8
0.00
0.00
0.0
1.9
—
4.2
—
0
8
32
316
1.09
0.00
23.8
17.7
92.1
91.7
fl
0.15
32
309
30
294
1.11
0.00
17.5
14.9
4.1
4.1
mmol/l
0.64
30
287
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
105.6
—
0
8
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
8
78
1.03
0.00
4.5
4.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
68.2
—
0
7
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
17.7
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MALE_GEN_NOS_EXALLC – Benign neoplasm: Male genital organ, other/unspecified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).